Chemical Compound
(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate (1:1); 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); CP 690500-10; CP 690550-10; Tasocitinib citrate; Tofacitinib citrate; Xeljanz
CAS Registry Number
540737-29-9
Primary record
(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate (1:1); 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); CP 690500-10; CP 690550-10; Tasocitinib citrate; Tofacitinib citrate; Xeljanz
- 库存
- 8,347 克
- 纯度
- 98.4 %
- CAS
- 540737-29-9
化合物标识与属性
- CAS
- 540737-29-9
- PubChem CID
- 10174505
- SMILES
- C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
- Canonical SMILES
- C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O
名称与同义词
- Tofacitinib citrate
- Tasocitinib citrate
- Xeljanz
- 540737-29-9
- Tofacitinib
- Xeljanz Xr
- CP-690550 citrate
- Tofacitinib (citrate)
- Tasocitinib monocitrate
- citro; tofacitinib
- Racemic Tasocitinib
- Tofacitinib monocitrate
- Xeljanz (TN)
- Tofacitinib (CP-690550) Citrate
- O1FF4DIV0D
- tofacitinib citric acid
- Tofacitinib citrate [USAN]
- UNII-O1FF4DIV0D
- RefChem:56139
- CP 690550 citrate
- Tofacitinib citrate (API)
- Tasocitinib citric acid salt
- CEP-18770(Delanzomib)
- 540737-29-9 (citrate)
- CHEBI:71197
- MLS006010058
- DTXSID80202404
- MFCD11616529
- C22H28N6O8
- orb1305543
- SCHEMBL1374185
- CHEMBL2103743
- CP-690550-10
- SCHEMBL29351190
- Tofacitinib citrate (JAN/USAN)
- AMY4175
- CP-690,550-10
- DTXCID40124895
- EX-A204
- TOFACITINIB CITRATE [JAN]
- Tofacitinib citrate(CP690550)
- SYIKUFDOYJFGBQ-YLAFAASESA-N
- Tofacitinib (citrate) (Standard)
- GLXC-90059
- HY-40354AR
- AOB87768
- CP-690550
- TOFACITINIB MONOCITRATE [MI]
- CP-690
- HB1427
- HY-40354A
- MFCD23703608
- s5001
- TOFACITINIB CITRATE [WHO-DD]
- AKOS022178222
- CP-690550 - Tofacitinib citrate
- Tofacitinib citrate, >=98% (HPLC)
- ACN-037647
- CCG-269730
- CS-0928
- EBC-154099
- CID10174505
- CP-690550 Citrate (Tofacitinib Citrate)
- TOFACITINIB CITRATE [ORANGE BOOK]
- AC-25004
- AS-19392
- BC600313
- BT163661
- CID 10174505
- CP690550
- DA-78526
- SC-12808
- SMR004701220
- SY069413
- Tofacitinib citrate, 99% - 10MG 10mg
- AB0033779
- C16-H20-N6-O.C6-H8-O7
- CP 690550
- CP 690550 citrate (Tofacitinib citrate)
- Tofacitinib citrate (CP-690550 citrate)
- A4135
- CP-690,550
- FT-0665216
- ST24050181
- X7518
- CP 690550-10
- D09783
- Q-3287
- 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
- EN300-7423761
- Q27139435
- 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)- beta-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- 2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
- Z2235801937
- 2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
- (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-?-oxo-1-piperidinepropanenitrile citrate
- (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-|A-oxo-1-piperidinepropanenitrile 2-hydroxy-1,2,3-propanetricarboxylate
- (3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidine propanenitrile 2-hydroxy-1,2,3-propanetricarboxylate
- (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate (1:1); 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); CP 690500-10; CP 690550-10; Tasocitinib citrate; Tofacitinib citrate; Xeljanz
- 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
- 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-beta-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
- 1-PIPERIDINEPROPANENITRILE,4-METHYL-3- -BETA-OXO-, -,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE
- 1-PIPERIDINEPROPANENITRILE,4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-,(3R,4R)-,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE(1:1)
- 1092578-47-6
- 1259404-17-5
- 2-Hydroxypropane-1,2,3-tricarboxylic acid--3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile (1/1)
- 3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXO-PROPANENITRILE2-HYDROXYPROPANE-1,2,3-TRICARBOXYLATE (1:1)
- 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile mono citrate salt
- 3-[(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidyl]-3-oxopropanenitrile 2-Hydroxypropane-1,2,3-tricarboxylate
- 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
- 3-{(3r,4r)-4-methyl-3-[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate salt
- 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile Mono Citrate Salt
- 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl}-amino]-piperidin-1-yl)-3-oxo-propionitrile citrate salt
- citric acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidyl]-3-oxo-propanenitrile